Navigation Links
Levels of Biomarkers After ACL Surgery May Signal Severity of Osteoarthritis Later in Life
Date:3/18/2017

Levels of Biomarkers After ACL Surgery May Signal Severity of Osteoarthritis Later in Life

San Diego, CA – A majority of Anterior Cruciate Ligament (ACL) reconstruction patients develop a condition known as posttraumatic osteoarthritis (PTOA) within 15 years of surgery, which can be debilitating and limit activity. Researchers presenting their work at the American Orthopaedic Society for Sports Medicine’s (AOSSM) Specialty Day in San Diego are highlighting how a set of biomarkers on the day of surgery may explain why some individuals have worse PTOA than others after two years.

“Previous studies demonstrated how ACL injury triggers a biochemical process that worsens after the first 4-6 weeks of injury. Our research notes that higher levels of collagen breakdown at the time of surgery, may correlate to worse outcomes at two years,” said lead author of the study, Christian Lattermann, MD of the University of Kentucky.

Lattermann and his colleagues studied 18 patients (9 females and 9 males ranging in age from 14 – 32 years) with an ACL injury. These individuals were previously enrolled in a prospective randomized trial evaluating early anti-inflammatory treatment after ACL injury. As part of the initial trial, synovial, serum, and urinary biomarkers of chondrodegeneration and inflammation were collected on the day of the surgery. The researchers utilized a variety of outcomes measures, including the KOOS-QOL scores to analyze results.

“Our data strongly suggests that initial biochemical changes after injury may have powerful consequences that cannot be mitigated by surgical stabilization alone,” notes Lattermann. “These results also create an opportunity to learn more about how early interventions with anti-inflammatory medications, may help lessen osteoarthritis risks in ACL patients, especially those patients with high levels of a particular biomarker.”

###

The American Orthopaedic Society for Sports Medicine (AOSSM) is a world leader in sports medicine education, research, communication and fellowship, and includes national and international orthopaedic sports medicine leaders. The Society works closely with many other sports medicine specialists, including athletic trainers, physical therapists, family physicians, and others to improve the identification, prevention, treatment, and rehabilitation of sports injuries. AOSSM is also a founding partner of the STOP Sports Injuries campaign to prevent overuse and traumatic injuries in kids.

Read the full story at http://www.prweb.com/releases/2017/03/prweb14148976.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Why Dairy Proteins May Be the Answer to Controlling Insulin and Blood Glucose Levels
2. Pixel Film Studios Recently Released ProSlice Levels for Final Cut Pro X
3. Adults at Risk for Diabetes Double Activity Levels
4. 2016 ‘State of the Air’ Report Finds More than Half of Americans Live with Unhealthful Levels of Air Pollution
5. World Patent Marketing Invention Team Introduces Diakitex, a Breakthrough Medical Invention That Will Help Diabetic Patients Manage Their Blood Sugar Levels
6. Fowl Play: Research from airmid healthgroup Finds High Levels of Contaminants in Newly Purchased Feather and Down Bedding
7. WEDI Releases Industry Survey to Gauge Levels of Interest in Specific Healthcare Focus Areas
8. Study on Enzyme and Acid Levels adds Another Health Benefit to Bariatric Surgery, Notes Dr. Michael Feiz
9. Recent Bariatric Study Reveals Good News for Diabetic Patients of All BMI Levels, Notes Dr. Michael Feiz
10. InventHelp Inventor Develops Tester for Hormone Levels (LAX-426)
11. Cannabis Dispensary CEO Comments in Blog Posting on How Consumers Are Influencing the Potency Levels of Legal Marijuana
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 2017 , ... As President Trump challenges the status quo ... administration could impact the employee benefits industry. James Slotnick, AVP, Government Relations, for ... make it through Congress. His discussion will focus on the current state of ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... modern procedure that achieves results in a fraction of the time as traditional ... NV, with Significance Dental Specialists, now offers this revolutionary treatment with or without ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the ... dispensaries and head shops –can’t help but be heartened by the industry’s current surge. ... odor aptly described as “skunk smell.” At last they can simply, safely and ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better ... according to a special report in the May issue of Consumer Reports focused on ... quality ranking for results achieved during and after coronary bypass and aortic valve replacement ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American ... pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in a ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... Uro/Gyn and Gynecology markets with innovative and proprietary ... the Company as Senior Vice President, Marketing & ... Keswani will report directly to Darin Hammers ... is delighted that Ash has joined the Cogentix ...
(Date:4/20/2017)... DUBLIN , April 20, 2017 Research ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ... to their offering. ... market for drug delivery technologies will rise from USD 20 Billion ... Global Drug Delivery Technologies - Innovation Driven by Rapidly ...
(Date:4/20/2017)... April 20, 2017 Eyevensys, a ... first non-viral gene expression technology that enables the safe, ... to address a wide range of ophthalmic diseases, announces ... Healthcare products Regulatory Agency (MHRA) to advance its technology ... ...
Breaking Medicine Technology: